Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04255615 · ClinicalTrials.gov registry record · NA
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
A NA study of Infertility and ART, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 4,000
- Enrollment target
- 1
- Study location
NCT04255615: Recruiting NA study of Infertility and ART, sponsored by Weill Medical College of Cornell University.
NCT04255615 is a NA study of Infertility and ART that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 4,000 participants, below the 7,535-participant average among 74 other Infertility trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04255615, a NA study of Infertility and ART, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The use of machine learning techniques using an artificial intelligence tool is proposed to analyze clinical data to predict best possible IVF/ART outcomes. This tool has been utilized to accurately predict embryo quality here at Cornell. Utilizing this tool to assess objective clinical findings and predict outcomes of assisted reproductive techniques is sought, with the ultimate goal of an automated tool to reduce implicit physician bias. Within this goal, using this tool to objectively and accurately assess baseline ovarian reserve at the start of an ART cycle is proposed, using 3D sonography to image the ovary and artificial intelligence tool to objectively identify baseline antral follicle counts.
Primary Outcome
To assess the accuracy and feasibility of using our artificial intelligence tool to assess antral follicle count, an indicator of baseline ovarian reserve, at time of baseline ultrasound for ART compared to qAVCantral and manual follicle counts to number of total oocytes retrieved.
Conditions Studied
Interventions
- OTHER AI to analyze 3 D ultrasound
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2029-09-30 |
| Phase | NA |
What NCT04255615 shows while recruiting
NCT04255615 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, below the 7,535-participant average among 74 other Infertility trials with a reported enrollment target (47% lower).
The record links to 3 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which AI to analyze 3 D ultrasound is the first listed.
NCT04255615 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04255615 about?
NCT04255615 is a clinical study titled "Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes". The use of machine learning techniques using an artificial intelligence tool is proposed to analyze clinical data to predict best possible IVF/ART outcomes. This tool has been utilized to accurately predict embryo quality here at Cornell. Utilizing this tool to assess objective clinical findings and...
What is the current status of trial NCT04255615?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2020-02-12. Estimated completion is 2029-09-30.
What conditions does trial NCT04255615 study?
This clinical trial studies the following conditions: Infertility, ART, in Vitro Fertilization (IVF).
What interventions are being tested in trial NCT04255615?
The interventions under investigation include: AI to analyze 3 D ultrasound (OTHER).
Who is sponsoring clinical trial NCT04255615?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04255615 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04255615's enrollment target sits among peer trials
4,000 4th of 74 higher than 71 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Testicular Tissue Cryopreservation in Children
RECRUITING · NA
-
Sex Selection of Human Spermatozoa
RECRUITING · NA
-
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
RECRUITING · NA
-
A Prospective Study of a Mosaic Embryo Transfer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI